Economic impact of drug-eluting stents on hospital systems: a disease-state model
- 31 March 2004
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 147 (3), 449-456
- https://doi.org/10.1016/j.ahj.2003.11.005
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- First Clinical Experience With a Paclitaxel Derivate–Eluting Polymer Stent System Implantation for In-Stent RestenosisCirculation, 2002
- Making choices in cardiology: difficulties of rationing and equality of accessInternational Journal of Cardiology, 2001
- Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel DiseaseNew England Journal of Medicine, 2001
- Steroids for restenosis: Strike three!American Heart Journal, 1999
- Evaluation of the cost-effectiveness of coronary stenting: A societal perspectiveAmerican Heart Journal, 1999
- Repeat coronary angioplasty as the treatment of choice for restenosisAmerican Heart Journal, 1996
- The Use of Low-Osmolar Contrast Agents: Technological Change and Defensive MedicineJournal of Health Politics, Policy and Law, 1996
- Small stent size and intimal hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysisJournal of the American College of Cardiology, 1995
- Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial InfarctionNew England Journal of Medicine, 1995